Prostate Cancer Trial, Recruiting NCT07324798 Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences Condition: Prostate Cancer
Back to Prostate Cancer

Prostate Cancer Trial, Recruiting

NCT07324798
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with a urological (urinary system or related organ) tumour that is either newly diagnosed, has spread to other parts of the body, or has come back, and where the diagnosis has been confirmed through laboratory testing of tissue
  • People whose medical team has assessed them as suitable for a type of radiation treatment that adjusts during the course of treatment
  • People aged 18 years or older
  • People with a general health and activity level rated between 0 and 2 on a standard medical scale, meaning they are fully active or able to carry out light work (confirm with trial site)
  • People who have not previously received radiation treatment to the same area of the body being targeted in this trial
  • People who have no medical reasons preventing them from having an MRI scan
  • People who have no medical reasons preventing them from receiving radiotherapy

Who may not be able to join:

  • People who have medical reasons that make radiotherapy unsafe or unsuitable for them
  • People who are unable to tolerate an MRI scan, or who have medical reasons that make MRI scanning unsafe for them

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 22 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 861018611804268

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Registry
ClinicalTrials.gov
Start date
1 December 2024
Est. completion
31 December 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Acute GU and GI toxicities as per NCI-CTC 5.0 criteria 3-months post RT

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov